Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAPAZ: Pazopanib and Paclitaxel in Ovarian Cancer
NCT02383251Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Jun 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, sponsored by ARCAGY. Started Jun 2015; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02383251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383251.